AU2019313506A1 - New myokines and uses thereof - Google Patents

New myokines and uses thereof Download PDF

Info

Publication number
AU2019313506A1
AU2019313506A1 AU2019313506A AU2019313506A AU2019313506A1 AU 2019313506 A1 AU2019313506 A1 AU 2019313506A1 AU 2019313506 A AU2019313506 A AU 2019313506A AU 2019313506 A AU2019313506 A AU 2019313506A AU 2019313506 A1 AU2019313506 A1 AU 2019313506A1
Authority
AU
Australia
Prior art keywords
polypeptide
amino acid
acid sequence
seq
muscle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019313506A
Other languages
English (en)
Inventor
Holger Hoefling
Hansjörg KELLER
Sophie LEMIRE
Serge SUMMERMATTER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2019313506A1 publication Critical patent/AU2019313506A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4725—Proteoglycans, e.g. aggreccan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2019313506A 2018-08-02 2019-07-31 New myokines and uses thereof Abandoned AU2019313506A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18187131.0 2018-08-02
EP18187131 2018-08-02
PCT/IB2019/056537 WO2020026167A1 (en) 2018-08-02 2019-07-31 New myokines and uses thereof

Publications (1)

Publication Number Publication Date
AU2019313506A1 true AU2019313506A1 (en) 2021-01-14

Family

ID=63144838

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2019313506A Abandoned AU2019313506A1 (en) 2018-08-02 2019-07-31 New myokines and uses thereof

Country Status (10)

Country Link
US (1) US20220144908A1 (https=)
EP (1) EP3829620B1 (https=)
JP (1) JP2021533113A (https=)
KR (1) KR20210041580A (https=)
CN (1) CN112512553A (https=)
AU (1) AU2019313506A1 (https=)
CA (1) CA3106518A1 (https=)
IL (1) IL280369A (https=)
TW (1) TW202019457A (https=)
WO (1) WO2020026167A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113424794B (zh) * 2021-04-16 2022-07-26 安徽农业大学 一种优质抗病型地方鸡新品系选育方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001522239A (ja) 1997-03-21 2001-11-13 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド ８７個のヒト分泌タンパク質
JP2003502004A (ja) 1997-10-02 2003-01-21 ジェネティックス・インスチチュート・インコーポレーテッド 分泌蛋白およびそれらをコードするポリヌクレオチド
CA2311201A1 (en) 1999-08-05 2001-02-05 Genset S.A. Ests and encoded human proteins
WO2003004532A2 (en) * 2001-07-05 2003-01-16 Geneprot, Inc. Q9ul33/q9nzz4 and q9h5p3 splice variants
JP2004313167A (ja) * 2003-02-24 2004-11-11 Joji Inasawa 薬剤耐性マーカーおよびその利用

Also Published As

Publication number Publication date
US20220144908A1 (en) 2022-05-12
JP2021533113A (ja) 2021-12-02
CA3106518A1 (en) 2020-02-06
IL280369A (en) 2021-03-01
TW202019457A (zh) 2020-06-01
CN112512553A (zh) 2021-03-16
KR20210041580A (ko) 2021-04-15
EP3829620A1 (en) 2021-06-09
WO2020026167A1 (en) 2020-02-06
EP3829620B1 (en) 2024-05-29

Similar Documents

Publication Publication Date Title
JP7829511B2 (ja) Ｌａｒファミリーホスファターゼの活性を阻害する組成物及び方法
JP6786544B2 (ja) 成長ホルモン断片の使用
TWI427084B (zh) 穩定化之類胰島素生長因子多肽
RU2764197C1 (ru) Аналоги инсулина с пониженной аффинностью к рецептору инсулина и их применение
EA035158B1 (ru) Пептиды и композиции для лечения повреждений суставов
BR112015023409B1 (pt) Complexo iônico, composição farmacêutica compreendendo o referido complexo, seu uso e métodos de produção do referido complexo
Zhu et al. Potential of food protein-derived bioactive peptides against sarcopenia: a comprehensive review
CA3149188A1 (en) Materials and methods for treating friedreich's ataxia
JP2023116739A (ja) Ａｐｏｃ－ｉｉ模倣ペプチド
CN101610783A (zh) 脊髓损伤治疗剂
EP1294866B1 (en) Use of acrp30 globular head to promote increases in muscle mass and muscle differentiation
EP3829620B1 (en) New myokines and uses thereof
AU754982B2 (en) Compositions for promoting nerve regeneration
EP2864353B1 (en) Selective cartilage therapy
EP2862577B1 (en) Use of obestatin for muscle regeneration
JP2019525931A (ja) ヒト成長ホルモンアナログによる成人成長ホルモン欠乏症の処置
KR20230142502A (ko) 골관절염 통증 치료를 위한 link-tsg6의 용도
EA042134B1 (ru) МИМЕТИЧЕСКИЕ ПЕПТИДЫ apoC-II
HK40005790A (en) Insulin analog having reduced binding force to insulin receptor, and use thereof
HK1133822A (en) Stabilized insulin-like growth factor polypeptides
AU2006203279A1 (en) Use of ACRP30 globular head to promote increases in muscle mass and muscle differentiation

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application